It is prescribed for individuals with a body mass index (BMI) of 30 or greater or those with a BMI between 27 and 30 who have weight-related health conditions, such as high blood pressure or type 2 diabetes Ozempic (Semaglutide) , while effective for weight loss in some clinical trials, is approved in Singapore for diabetes management, not as a dedicated weight loss treatment
Your provider will determine whether Semaglutide or Tirzepatide is the better fit based on your health history and treatment goals
Matt Lesser, a Middletown Democrat and co-chair of the Human Services Committee, who sponsored the prescription drug legislation with members of the Bipartisan Drug Task Force, said there are a number of legal and practical questions that the state must address to make a compelling case to the federal government to manufacture the drug
The SURMOUNT-4 trial data shows that stopping tirzepatide entirely leads to significant weight regain, so maintaining some level of medication support, even at reduced doses, appears to produce better long-term outcomes than complete cessation